👉 Read the full article here: lnkd.in/e7tA84j4

✔️ Outcomes for people with diabetes
✔️ Goals for personalised medicine
✔️ Implications for guideline-based services and healthcare professionals

Their work resulted in 14 actionable recommendations to bring AI-CDSS from theory into real-world clinical settings.

The group examined the objectives for good diabetes care in the context of current and predicted AI-driven clinical decision support systems (AI-CDSS), including:

To explore this potential, the EUDF convened a working group to identify unmet needs and practical steps for implementing AI in clinical practice.

And as Prof. Chantal Mathieu reminded us: “Research will cure this disease.”

📄 Want to learn more?

Read our full event report and discover how disease-modifying therapies can transform diabetes care: lnkd.in/eKz2wV8C

As Carmen Hurtado put it: “In Europe, we have two options: wait, or act now. Preparing now will be crucial to ensure healthcare systems are ready to deploy DMTs.”
DMTs have huge potential. We must support researchers and work together to make sure they reach people with diabetes as soon as possible.

🏛️On November 4, we explored their exciting potential during an event at the European Parliament, organised together with EDENT1FI.

Our speakers shared insights on recent progress and discussed how Europe can prepare its healthcare systems for these groundbreaking therapies.

What if we could prevent or even cure diabetes? That’s the promise of disease-modifying therapies (DMTs) - and they’re no longer science fiction 🚀

In fact, @ema.europa.eu has just recommended the approval of the first-ever treatment to delay the onset of type 1 diabetes (lnkd.in/eiiwdRgu).

Since then, #insulin has saved millions of lives and remains the cornerstone of diabetes treatment. Yet, despite clinical and technological advances, diabetes continues to place a heavy burden on people living with it and their families.

💡 But what if treatment wasn’t the only answer?

🙏 A heartfelt thank you to everyone who joined us and helped make this event a success. Change is happening—and we now have a real opportunity to transform how we diagnose and treat type 1 diabetes 💙.

Read the article here: lnkd.in/eZvp9WBj

“When we bring together people with knowledge, lived experience, and political will, we reach a whole new level of action. We can – and should – do more to advance the early detection of Type 1 Diabetes.”

🤝 At the heart of all this progress is one key message: collaboration and partnership matter. Together, we are stronger - and together, we can achieve more.

That message was highlighted by MEP @stinebosse.bsky.social, who hosted our event:

🧪 Introducing routine antibody screening
👩‍⚕️ Equipping healthcare professionals through training and updated care pathways
🔬 Strengthening research and regulatory frameworks to ensure timely access to innovation

🏥 These therapies are emerging fast, and it’s crucial that our healthcare systems are prepared to integrate them.

The science is advancing - now it’s time for policy to catch up. That means:

The article explores the vital work of European initiatives like the @ihieurope.bsky.social-funded EDENT1FI project. It also delves into the growing promise of disease-modifying therapies - treatments that could delay, and one day potentially cure, type 1 diabetes.

🔬 Authored by Prof. Chantal Mathieu, Carmen Hurtado, Prof. Emanuele Bosi, Finn Kristensen, and Jurgen Vercauteren, the piece highlights the remarkable progress made in recent years around early detection of type 1 diabetes.

🏛️Later today, @sant.europarl.europa.eu will meet to discuss its own-initiative report. We sincerely hope the Committee will support a bold, inclusive, and forward-looking Plan - one that truly improves the lives and health of European citizens 💙.

Read our Shadow Plan here: lnkd.in/e_AheHga

📙In our EUDF Shadow CV Plan, we call for a comprehensive, integrated approach to preventing, diagnosing, and treating cardiometabolic diseases - diabetes, obesity, and CVD. Tackling these conditions together is the only way to drive real change and improve the health of people across Europe.

We were honoured to welcome MEP Romana Jerković, Rapporteur for the European Parliament’s report on an EU Cardiovascular Diseases Strategy. She emphasised the interconnection between CVD, diabetes, and other cardiometabolic conditions - and the need for the Plan to reflect this reality.